Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

GLP-1 Receptor Agonist-Induced Muscle Mass Evaluation and Retention

NCT07272837 is registered in ClinicalTrials.gov with University of Alberta as lead sponsor.

NCT NCT07272837
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07272837 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
GLP-1 Receptor Agonist-Induced Muscle Mass Evaluation and Retention
Lead sponsor
University of Alberta
Phase
Observational
Overall status
Recruiting
Start date
May 15, 2026
Completion date
April 30, 2028
Enrollment
50 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

diabetes, glp-1, obesity, semaglutide, type 2 diabetes